A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane-based regimens
2018 ◽
Vol 14
(5)
◽
pp. e231-e237
◽
2019 ◽
Vol 145
(12)
◽
pp. 3359-3369
◽
Keyword(s):
2010 ◽
Vol 8
(3)
◽
pp. 197-198
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. e11539-e11539
◽
2015 ◽
Vol 51
◽
pp. S290
◽
2011 ◽